Latest Articles

Publication Date
Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts - Inshorts

Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts Inshorts

Published: Nov. 26, 2025, 11:03 a.m.
Network pharmacology prediction of UA in targeting endometriosis progression to endometrial cancer.

Endometriosis is a gynecological disorder predominantly affecting women of reproductive age and is considered a potential risk factor for the development of endometrial cancer. However, the molecular mechanisms underlying the …

Published: Nov. 26, 2025, midnight
A STEM educator battles rare endometrial cancer - UT Physicians

A STEM educator battles rare endometrial cancer UT Physicians

Published: Nov. 25, 2025, 9:25 p.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 25, 2025, 2:06 p.m.
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer - NAVLIN DAILY

HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 24, 2025, 12:18 p.m.
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …

Published: Nov. 24, 2025, midnight
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer - Oncodaily

Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer Oncodaily

Published: Nov. 21, 2025, 4:19 p.m.
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - This is Money

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug This is Money

Published: Nov. 21, 2025, 11:48 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - springermedicine.com

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression springermedicine.com

Published: Nov. 21, 2025, 2:26 a.m.
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? - ASCO Daily News

What Is the Role of ctDNA in Ovarian and Endometrial Cancers? ASCO Daily News

Published: Nov. 21, 2025, 2:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!